Free Trial

Ocular Therapeutix (OCUL) Insider Trading & Ownership

Ocular Therapeutix logo
$8.50 +0.05 (+0.59%)
(As of 12/20/2024 05:16 PM ET)

Ocular Therapeutix (NASDAQ:OCUL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7.00 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$251,227.98
Get OCUL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ocular Therapeutix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OCUL Insider Buying and Selling by Quarter

Ocular Therapeutix Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2024Jeffrey S HeierInsiderSell2,948$9.01$26,561.48  
8/23/2024Sanjay NayakInsiderSell1,832$9.02$16,524.64  
5/23/2024Sanjay NayakInsiderSell2,274$5.84$13,280.16  
2/26/2024Summer Road LlcMajor ShareholderBuy930,851$7.52$6,999,999.52  
1/31/2024Antony C MattessichCEOSell18,338$4.95$90,773.10  
1/31/2024Donald NotmanCFOSell6,433$4.95$31,843.35  
1/31/2024Philip C StrassburgerGeneral CounselSell6,831$4.95$33,813.45  
1/31/2024Rabia Gurses OzdenInsiderSell7,764$4.95$38,431.80  
(Data available from 1/1/2013 forward)

OCUL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Ocular Therapeutix includes Antony C Mattessich, Christopher G White, Donald Notman, Jeffrey S Heier, Philip C Strassburger, Rabia Gurses Ozden, Sanjay Nayak, and Summer Road Llc. Learn more on insiders at OCUL.

3.50% of Ocular Therapeutix stock is owned by insiders. Learn more on OCUL's insider holdings.

The following insiders have purchased OCUL shares in the last 24 months: Antony C Mattessich ($24,765.00), and Summer Road Llc ($6,999,999.52).

Insiders have purchased a total of 937,351 OCUL shares in the last 24 months for a total of $7,024,764.52 bought.

The following insiders have sold OCUL shares in the last 24 months: Antony C Mattessich ($174,169.66), Christopher G White ($24,714.96), Donald Notman ($59,301.59), Jeffrey S Heier ($26,561.48), Philip C Strassburger ($60,020.89), Rabia Gurses Ozden ($42,533.56), and Sanjay Nayak ($29,804.80).

Insiders have sold a total of 85,407 Ocular Therapeutix shares in the last 24 months for a total of $417,106.94 sold.

Ocular Therapeutix Key Executives

  • Mr. Donald Notman Jr.
    CFO, COO & Principal Accounting Officer
  • Dr. Jeffrey S. Heier M.D. (Age 63)
    Chief Scientific Officer
    Compensation: $86.16k
  • Dr. Pravin U. Dugel M.D. (Age 60)
    Executive Chairman, President & CEO
  • Dr. Peter K. Jarrett Ph.D. (Age 67)
    Chief Technology Officer
  • Mr. William S. Slattery Jr.
    Vice President of Investor Relations
  • Mr. William H. Ransone II
    Vice President of Global Sales & Marketing
  • Ms. Tracy Smith
    Vice President of Human Resources
  • Mr. Steve Meyers
    Chief Commercial Officer
  • Dr. Peter K. Kaiser M.D.
    Chief Development Officer
  • Mr. Sanjay Nayak MBBS (Age 54)
    Ph.D., Chief Strategy Officer


This page (NASDAQ:OCUL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners